Longitudinal Patterns of Chemotherapy Use in Metastatic Colorectal Cancer
Author:
Affiliation:
1. Cancer Center Biostatistics; Division of Medical Oncology, Department of Medicine; and Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC
Abstract
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Health Policy,Oncology (nursing),Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JOP.091010
Reference17 articles.
1. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
3. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)
4. CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer
5. The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal Cancer
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Real-world usage of bevacizumab-bvzr biosimilar in US oncology practice;The American Journal of Managed Care;2022-02-09
2. Comparative Effectiveness of Biologic Agents Among Black and White Medicare Patients in the US With Metastatic Colorectal Cancer;JAMA Network Open;2021-12-15
3. Utilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017;Journal of the American Academy of Dermatology;2021-11
4. A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK;Journal of Medical Economics;2020-12-01
5. Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer;Journal of Cancer Research and Clinical Oncology;2020-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3